Agilent Technologies A Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net revenue by Business | |||||
| Agilent CrossLab | $2.91B+5.9% | $2.75B+3.4% | $2.66B+82.9% | $1.45B+6.8% | |
| Applied Markets | $1.31B+1.3% | $1.3B-7.2% | $1.4B— | —— | |
| Life Sciences and Diagnostics Markets | $2.73B+10.5% | $2.47B-11.3% | $2.78B— | —— | |
| Income from operations by Business | |||||
| Agilent CrossLab | $946M+2.3% | $925M+10.3% | $839M+127% | $370M+14.6% | |
| Applied Markets | $301M-3.5% | $312M-14.0% | $363M— | —— | |
| Life Sciences and Diagnostics Markets | $536M+10.7% | $484M-28.1% | $673M— | —— | |
| Foreign currency translation impact by Business | |||||
| Applied Markets | $0-100% | $4M— | —— | —— | |
| Goodwill by Business | |||||
| Agilent CrossLab | $4.67B+140% | $1.95B-0.2% | $1.95B+86.5% | $1.05B-46.8% | |
| Applied Markets | $1.23B— | —— | —— | —— | |
| Life Sciences and Diagnostics Markets | $11.95B— | —— | —— | —— | |
| Net revenue by Product | |||||
| Instrumentation | $2.43B+3.1% | $2.35B-14.2% | $2.74B-5.7% | $2.91B+9.4% | |
| Non-Instrumentation and Other | $4.52B+8.8% | $4.16B+1.6% | $4.09B+3.8% | $3.94B+7.6% | |
| Services and Other | $2B+9.0% | $1.84B+3.1% | $1.78B+7.3% | $1.66B+6.3% | |
| Net revenue by Geography | |||||
| Americas | $2.81B+9.1% | $2.57B-5.8% | $2.73B+1.9% | $2.68B+11.6% | |
| Asia Pacific | $2.22B+2.4% | $2.17B-7.7% | $2.35B-4.9% | $2.47B+10.8% | |
| Europe | $1.92B+8.6% | $1.77B+0.9% | $1.75B+3.2% | $1.7B+0.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Agilent Technologies break its business down?
- Agilent Technologies (A) reports net revenue by business across 3 parts — Agilent CrossLab, Applied Markets and Life Sciences and Diagnostics Markets. Each is extracted from the segment footnotes and tracked over time.
- Where does Agilent Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Agilent Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
